Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.

Clinical trial NCT01336218 · COMPLETED

Trial details

NCT number: NCT01336218
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis Healthy Volunteers

Start date: 2011-04-01
Primary completion: 2011-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.